Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
I
|
Intercontinental Exchange Inc
SWB:IC2
|
US |
|
China Construction Bank Corp
SSE:601939
|
CN |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
S
|
Sonic Automotive Inc
SWB:SA8A
|
US |
|
DKSH Holding AG
F:DS5
|
CH |
|
P
|
PPC Ltd
SWB:OZV2
|
ZA |
|
D
|
DBA Group SpA
MIL:DBA
|
IT |
|
Quanterix Corp
NASDAQ:QTRX
|
US |
|
Teleperformance SE
PAR:TEP
|
FR |
|
S
|
Standard Motor Products Inc
F:SRU
|
US |
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
US |
|
Amcor PLC
F:4850
|
CH |
|
Q
|
Qualcomm Inc
XMUN:QCI
|
US |
|
Lucisano Media Group SpA
MIL:LMG
|
IT |
|
MercadoLibre Inc
BMV:MELIN
|
UY |
DCF Value
The DCF Value for
Coherus BioSciences Inc (CHRS) under the Base Case is hidden
USD.
Compared with the current market price of 1.44 USD, the stock appears hidden
.
DCF Model
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
Our valuation system just got a major upgrade
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more